Skip to main content

Table 1 Patients characteristics

From: Global expression of AMACR transcripts predicts risk for prostate cancer – a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate

Number of patients

79

Age at surgery (years) Average (min,max)

61.5 (48, 71)

Preoperative serum PSA Average (min,max)

8.4 (1.4, 30)

Pathological T-category

Number of samples (percentage)

 

pT2

33 (42 %)

pT3 and pT4

41 (52 %)

Unknown

5 (6 %)

Pathological Gleason score

 
 

≤6

45 (57 %)

7

18 (23 %)

≥8

12 (15 %)

Unknown

4 (5 %)